The Taiwan Biomedical Innovation Association (TiBIA) announced on the 21st that its president, Yun Yen, has been named a Fellow of the American Society of Clinical Oncology (FASCO). This prestigious lifetime achievement award recognizes his outstanding contributions to cancer clinical research and his dedicated efforts in promoting ASCO’s educational initiatives.
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the largest professional organization in clinical oncology, wielding significant influence in the cancer field. With over 50,000 members from more than 150 countries, approximately one-third of its members are international. Established in 2007, the FASCO designation honors ASCO members who have demonstrated exemplary commitment and contributions to the oncology field, representing the society's highest accolade and inspiring others to advance cancer research and care.
The FASCO award will be officially conferred during ASCO’s annual meeting, which will be held in Chicago, USA, on May 31, 2025. Renowned as the world’s largest and most prominent conference on cancer and biomedical science, the ASCO annual meeting attracts clinical oncology experts, academics, healthcare professionals, pharmaceutical companies, biotech firms, and insurers from across the globe. It serves as a platform for advancing cancer treatment through cutting-edge clinical research and interdisciplinary international collaboration, ultimately promoting human health and well-being.
Yun Yen is a distinguished oncologist and scholar, actively engaged in the biomedical technology industry. He previously served as the Vice President of City of Hope Medical Center in the United States and as the Chair of its Cancer Therapeutics Research Program. He is also a Fellow of the National Academy of Inventors and the American Association for the Advancement of Science (AAAS).
While human lifespans continue to extend, cancer remains the leading threat to human life and health, presenting a persistent challenge in clinical medicine and academic research. “Identifying problems, researching problems, solving problems,” Yen remarked. Having witnessed countless instances of life and death in his clinical practice, he emphasized that as both a physician and a scholar, his mission is to relentlessly pursue medical innovation. This involves translating laboratory discoveries into clinical applications and bringing unresolved clinical issues back to the laboratory for further exploration. By continuously cycling between research and practice, better treatments can be developed, ultimately offering patients improved care and outcomes.
Resource: 閻雲獲ASCO授予終身會士
